BLFY BLUE FDRY BANCORP

Blue Foundry Bancorp Names Elizabeth Varki Jobes, Esq. to Board of Directors

Blue Foundry Bancorp Names Elizabeth Varki Jobes, Esq. to Board of Directors

Seasoned leader brings decades of legal and compliance expertise to the Board

RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (Nasdaq: BLFY) (the “Company”), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately.

James D. Nesci, President and Chief Executive Officer stated, “We are excited to welcome Ms. Jobes to Blue Foundry’s Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry.”

Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Before joining Amryt, Jobes served as Senior Vice President and Chief Compliance Officer of North America at EMD Serono. Ms. Jobes also served in leadership roles at Spark Therapeutics, Auxilium Pharmaceutical, and Cephalon. Prior to her career in the pharmaceuticals industry, Jobes held various roles within Philadelphia’s District Attorney’s Office from 1991 to 2006.

Ms. Jobes’ service on several boards demonstrates her invaluable leadership skills. She currently serves on the board of Ampio Pharmaceuticals, a public company, as well as the board of a private biopharmaceutical company (Eyam Vaccines and Immunotherapeutics), and the board of a not-for-profit organization.

Ms. Jobes is a member of the South Asian Bar Association and was a former board member of Women’s Way. She received her law degree from Rutgers University School of Law and is licensed to practice in both New Jersey and Pennsylvania.

Ms. Jobes commented, “I am eager to join Blue Foundry’s innovative culture and dynamic leadership team. I look forward to leveraging my experience to build upon the Bank’s exceptional reputation.”

About Blue Foundry Bancorp and Blue Foundry Bank

Blue Foundry Bancorp is the holding company for Blue Foundry Bank, a place where things are made, purpose is formed, and ideas are crafted. Headquartered in Rutherford NJ, with presence in Bergen, Essex, Hudson, Morris, Passaic and Somerset counties, Blue Foundry Bank is a full-service, innovative bank serving the doers, movers, and shakers in our communities. We offer individuals and businesses alike the tailored products and services they need to build their futures. With a rich history dating back more than 145 years, Blue Foundry Bank has a longstanding commitment to its customers and communities. 

Contacts:

James D. Nesci 

President and Chief Executive Officer

bluefoundrybank.com

 

201-972-8900



EN
05/01/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BLUE FDRY BANCORP

 PRESS RELEASE

Fulton Financial Corporation and Blue Foundry Bancorp Announce Regulat...

Fulton Financial Corporation and Blue Foundry Bancorp Announce Regulatory Approvals and Anticipated Merger Closing Date LANCASTER, Pa. and RUTHERFORD, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Fulton Financial Corporation (Nasdaq: FULT) (“Fulton”) and Blue Foundry Bancorp (Nasdaq: BLFY) (“Blue Foundry”) today jointly announced the receipt of all required regulatory approvals for the previously announced all-stock transaction pursuant to which Fulton will acquire Blue Foundry. Regulatory approvals have been granted by the Board of Governors of the Federal Reserve System and the Office of th...

 PRESS RELEASE

Fulton Financial Corporation and Blue Foundry Bancorp Combining in All...

Fulton Financial Corporation and Blue Foundry Bancorp Combining in All-Stock Merger Transaction Expands Fulton’s Presence in Highly Attractive New Jersey Markets LANCASTER, Pa. and RUTHERFORD, N.J., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fulton Financial Corporation (Nasdaq: FULT) (“Fulton”) and Blue Foundry Bancorp (Nasdaq: BLFY) (“Blue Foundry”) today announced that they have entered into a definitive merger agreement pursuant to which Fulton will acquire Blue Foundry in an all-stock transaction. Under the terms of the definitive merger agreement, each share of Blue Foundry common stock w...

 PRESS RELEASE

Blue Foundry Bancorp Reports Third Quarter 2025 Results

Blue Foundry Bancorp Reports Third Quarter 2025 Results RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $1.9 million, or $0.10 per diluted common share, for the three months ended September 30, 2025, compared to net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, and a net loss of $4.0 million, or $0.19 per diluted common share, for the three months ended September 30, 2024. James D. Nesci, Presid...

 PRESS RELEASE

Blue Foundry Bancorp Schedules Third Quarter 2025 Earnings Conference ...

Blue Foundry Bancorp Schedules Third Quarter 2025 Earnings Conference Call RUTHERFORD, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, October 29, 2025 it will release financial results for the quarter ended September 30, 2025. A copy of the earnings release will be available on the Company’s website, , in the “News” section and on the SEC’s website, . Representatives of the Company will hold a conference call for investors and analysts on Wednesday, October...

 PRESS RELEASE

Blue Foundry Bancorp Reports Second Quarter 2025 Results

Blue Foundry Bancorp Reports Second Quarter 2025 Results RUTHERFORD, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, compared to net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended March 31, 2025, and a net loss of $2.3 million, or $0.11 per diluted common share, for the three months ended June 30, 2024. James D. Nesci, President and Ch...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch